Investigators sought to determine whether alcohol intake, particularly at higher frequency or greater quantity, was consistently associated with elevated risk for cancer.

For patients with relapsed or refractory multiple myeloma, treatment with teclistamab plus daratumumab is associated with a significant PFS benefit.

Poherdy can be dispensed as a substitute for Perjeta without requiring a prescription change from a health care provider.

Investigators examined cervical cancer screening guideline adherence among a nationally representative commercially insured cohort in the US to identify factors and modalities associated with ...

Investigators sought to determine whether a single dose of HPV vaccine would provide similar protection as two doses.

Investigators compared patient-reported cancer-related cognitive impairment between pre- and postmenopausal women with breast cancer who received endocrine therapy with or without chemotherapy.

Some pediatric patients with low-risk acute myeloid leukemia (AML) can receive 4 cycles of chemotherapy, rather than 5, without affecting outcomes, according to research presented at the ASH Annual ...

The approval was based on data from the single-arm, open-label phase 2 KOMET-001 trial, which evaluated ziftomenib, a menin inhibitor, in adults with R/R AML with an NPM1 mutation.

In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Counties with the highest incarceration rates had 7% to 10% more deaths from lung, liver, and colorectal cancers. Counties with the highest rates of jail incarceration had significantly higher ...

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.